Research

A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.

These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB is joining the All of Us Research Program, an effort led by the National Institutes of Health to drive precision medicine research.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Due to the current opioid crisis, UAB Hospital has launched an Addiction Scholars Program to train health care professionals across the hospital in caring for patients with addiction issues.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The inhibitor blocks Streptococcus mutans from sticking on the tooth surface. About 2.3 billion people worldwide have tooth decay in their permanent teeth, primarily caused by this bacteria.
UAB, Alabama’s leader in precision medicine, joins with Huntsville’s HudsonAlpha in CSER2, an NIH project to bring genomic medicine to more children with birth defects or genetic disorders.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
Page 7 of 94
Back to Top